EODData

MEMBERSHIP REGISTER LOG IN

ASX, SPL: Starpharma Holdings Ltd.

07 Nov 2025
LAST:

0.3300

CHANGE:
 0.01		OPEN:
0.3400		HIGH:
0.3400		ASK:
0.0980		VOLUME:
1.87M
CHG(%):
3.03		PREV:
0.3300		LOW:
0.3200		BID:
0.0940		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 250.34000.34000.32000.33001.87M
06 Nov 250.33500.35000.33500.3400177.5K
05 Nov 250.33500.33500.32000.3300271.0K
04 Nov 250.34500.34500.32500.3350353.6K
03 Nov 250.34500.35000.32000.35001.49M
31 Oct 250.35000.35000.33000.3425289.1K
30 Oct 250.37000.37000.34500.35001.0M
29 Oct 250.33000.36500.33000.36502.19M
28 Oct 250.33500.33500.30500.3350809.0K
27 Oct 250.33000.34000.32500.3400849.3K

COMPANY PROFILE

Name:Starpharma Holdings Ltd.
About:Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It also involved in the development of a dendrimer-enhanced product (DEP) delivery platform, consisting of DEP SN38 for the treatment of ovarian and colorectal cancer that is in Phase II clinical trial; DEP cabazitaxel for prostate and ovarian cancer treatment that is in Phase II clinical trial; and DEP docetaxel to treat pancreatic and other cancers that is in Phase II clinical trial. In addition, the company is developing DEP HER2 radiodiagnostic and DEP HER2 ADC to treat solid tumors; DEP technology for antibody-drug conjugates; SPL7013 for vaginal gel, a treatment of bacterial vaginosis and prevention of recurrent BV, and an antiviral condom; and DEP HER2 radiodiagnostic. It has a collaboration agreement with Medicxi to develop petalion therapeutics, a novel cancer therapy using Starpharma's dendrimer technology. Starpharma Holdings Limited was incorporated in 1997 and is headquartered in Abbotsford, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:4-6 Southampton Crescent, Abbotsford, VIC, Australia, 3067
Website:https://starpharma.com
ISIN:AU000000SPL0
FIGI:BBG000BW3JT0

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-14.02 
Forward P/E:-16.75 
PEG Ratio:-16.75 
Price to Sales:23.95 
Price to Book:7.44 
Profit Margin:-1.71 
Operating Margin:-1.34 
Return on Assets:-0.20 
Return on Equity:-0.42 
EPS Ratio:-0.02 
Revenue:5.85M 
Shares:418.22M 
Market Cap:138.01M 

TECHNICAL INDICATORS

MA5:0.342.9%
MA10:0.343.4%
MA20:0.315.4%
MA50:0.2437.3%
MA100:0.1791.2%
MA200:0.14143.5%
STO9:25.00
STO14:62.50
RSI14:71.62 
WPR14:-33.33
MTM14:0.05
ROC14:0.17 
ATR:0.03 
Week High:0.3712.1%
Week Low:0.323.1%
Month High:0.3712.1%
Month Low:0.25143.5%
Year High:0.3712.1%
Year Low:0.08302.4%
Volatility:57.64